253 related articles for article (PubMed ID: 30018035)
1. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype.
Capule F; Tragulpiankit P; Mahasirimongkol S; Wichukchinda N; Jittikoon J; Alentajan-Aleta LT; James Barit JV; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; San Gabriel KF; Silao CL
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30018035
[TBL] [Abstract][Full Text] [Related]
2. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
3.
Capule F; Tragulpiankit P; Mahasirimongkol S; Jittikoon J; Wichukchinda N; Alentajan-Aleta LT; Barit JJ; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; Salonga R; San Gabriel KF; Silao CL
Pharmacogenomics; 2021 Jun; 22(8):465-472. PubMed ID: 33910375
[No Abstract] [Full Text] [Related]
4. Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients.
Capule F; Tragulpiankit P; Mahasirimongkol S; Jittikoon J; Wichukchinda N; Theresa Alentajan-Aleta L; James Barit JV; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; Salonga R; San Gabriel KF; Lynn Silao C
Pharmacogenomics J; 2020 Jun; 20(3):533-541. PubMed ID: 31896765
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Chaiyakunapruk N; Somkrua R; Lohitnavy M; Tassaneeyakul W
JAMA Dermatol; 2013 Sep; 149(9):1025-32. PubMed ID: 23884208
[TBL] [Abstract][Full Text] [Related]
6. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
Chang CC; Too CL; Murad S; Hussein SH
Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
[TBL] [Abstract][Full Text] [Related]
8. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Epilepsia; 2010 Dec; 51(12):2461-5. PubMed ID: 21204807
[TBL] [Abstract][Full Text] [Related]
9. [Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier – screening in risk patients is recommended].
Anastasopoulou S; Komuda M; Presman B; Karlsson M; Tomson T
Lakartidningen; 2017 Feb; 114():. PubMed ID: 28221394
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
Chen P; Lin JJ; Lu CS; Ong CT; Hsieh PF; Yang CC; Tai CT; Wu SL; Lu CH; Hsu YC; Yu HY; Ro LS; Lu CT; Chu CC; Tsai JJ; Su YH; Lan SH; Sung SF; Lin SY; Chuang HP; Huang LC; Chen YJ; Tsai PJ; Liao HT; Lin YH; Chen CH; Chung WH; Hung SI; Wu JY; Chang CF; Chen L; Chen YT; Shen CY;
N Engl J Med; 2011 Mar; 364(12):1126-33. PubMed ID: 21428768
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
[TBL] [Abstract][Full Text] [Related]
12. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
[TBL] [Abstract][Full Text] [Related]
13. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*31: 01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population.
Khor AH; Lim KS; Tan CT; Kwan Z; Tan WC; Wu DB; Ng CC
Pharmacogenet Genomics; 2017 Jul; 27(7):275-278. PubMed ID: 28570299
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
16. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhou P; Zhang S; Wang Y; Yang C; Huang J
J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
[TBL] [Abstract][Full Text] [Related]
17. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
Devi K
Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
[TBL] [Abstract][Full Text] [Related]
18. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
19. Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome.
Chomean S; Nakkam N; Tassaneeyakul W; Attapong J; Kaset C
Anal Biochem; 2022 Dec; 658():114931. PubMed ID: 36191668
[TBL] [Abstract][Full Text] [Related]
20. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
